BR0208654A - Composições veterinárias compreendendo derivados de avermectina-oxima e praziquantel - Google Patents

Composições veterinárias compreendendo derivados de avermectina-oxima e praziquantel

Info

Publication number
BR0208654A
BR0208654A BR0208654-9A BR0208654A BR0208654A BR 0208654 A BR0208654 A BR 0208654A BR 0208654 A BR0208654 A BR 0208654A BR 0208654 A BR0208654 A BR 0208654A
Authority
BR
Brazil
Prior art keywords
praziquantel
avermectin
oxime
derivatives
veterinary compositions
Prior art date
Application number
BR0208654-9A
Other languages
English (en)
Inventor
Bernard Frank Bishop
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR0208654A publication Critical patent/BR0208654A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSIçõES VETERINáRIAS COMPREENDENDO DERIVADOS DE AVERMECTINA-OXIMA E PRAZIQUANTEL". Terapia de combinação antiparasitária utilizando uma combinação de uma 13-monossacarídeo 5-oxima de avermectina, tal como a selamectina, e praziquantel.
BR0208654-9A 2001-04-04 2002-03-28 Composições veterinárias compreendendo derivados de avermectina-oxima e praziquantel BR0208654A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0108485.4A GB0108485D0 (en) 2001-04-04 2001-04-04 Combination therapy
PCT/IB2002/001025 WO2002094288A1 (en) 2001-04-04 2002-03-28 Veterinary compositions comprising avermectin-oxime derivatives and praziquantel

Publications (1)

Publication Number Publication Date
BR0208654A true BR0208654A (pt) 2004-03-09

Family

ID=9912257

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0208654-9A BR0208654A (pt) 2001-04-04 2002-03-28 Composições veterinárias compreendendo derivados de avermectina-oxima e praziquantel

Country Status (7)

Country Link
EP (1) EP1381374A1 (pt)
JP (1) JP2004526804A (pt)
BR (1) BR0208654A (pt)
CA (1) CA2443068A1 (pt)
GB (1) GB0108485D0 (pt)
MX (1) MXPA03009023A (pt)
WO (1) WO2002094288A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2620413T3 (es) * 2003-04-04 2017-06-28 Merial Ltd. Formulaciones veterinarias antihelmínticas tópicas
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
FR2936710B1 (fr) * 2008-10-07 2011-01-07 Ceva Sante Animale Composition veterinaire antiprolactinique destinee aux ruminants
BRPI1009199A2 (pt) 2009-03-17 2016-03-08 Concert Pharmaceuticals Inc compostos de pirazinoisoquinolina
GB0905365D0 (en) 2009-03-27 2009-05-13 Norbrook Lab Ltd A topical parasiticide composition
UA108641C2 (uk) 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
JP5723567B2 (ja) * 2010-08-06 2015-05-27 丸石製薬株式会社 含窒素複素環式化合物の定量方法
US9233100B2 (en) 2012-02-06 2016-01-12 Merial, Inc. Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
AU2013245011B2 (en) 2012-04-04 2017-11-23 Intervet International B.V. Solid oral pharmaceutical compositions for isoxazoline compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9300883D0 (en) * 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
BG61064B1 (bg) * 1993-08-12 1996-10-31 Илия Илиев Лекарствено средство за обезпаразитяване на животни
AUPM969994A0 (en) * 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
EP0959891A1 (en) * 1996-07-30 1999-12-01 Ashmont Holdings Limited Anthelmintic formulations
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations

Also Published As

Publication number Publication date
MXPA03009023A (es) 2004-02-12
CA2443068A1 (en) 2002-11-28
JP2004526804A (ja) 2004-09-02
GB0108485D0 (en) 2001-05-23
WO2002094288A1 (en) 2002-11-28
EP1381374A1 (en) 2004-01-21

Similar Documents

Publication Publication Date Title
HK1097828A1 (en) 42-0-alkoxyalkyl rapamycin derivatives and compositions comprising same
WO2005018551A3 (en) Oxime substituted imidazo-containing compounds
NZ526088A (en) Urea substituted imidazoquinoline ethers
SG148201A1 (en) Substituted imidazo ring systems and methods
BRPI0413234A (pt) derivados de imidazola bicìclica contra flaviviridae
ES2184705T3 (es) 4-oxo-4,7-dihidro-tieno(2,3-b)piridina-5-carboxamidas como agentes antivirales.
CY1110914T1 (el) Δικυκλο-πυραζολες δραστικες ως αναστολεις kinασων, διεργασια για την παρασκευη τους και φαρμακευτικες συνθεσεις που τις περιλαμβανουν
WO2005051324A3 (en) Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
MXPA04005038A (es) Solvatos de paclitaxel.
NO20070263L (no) Immunostimulerende oligonukleotidmultimerer
AU2002364730A8 (en) N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
HRP20020330B1 (pt)
BR0208654A (pt) Composições veterinárias compreendendo derivados de avermectina-oxima e praziquantel
CR7195A (es) Nuevos derivados de oxazolidinonas como antibacterianos
WO2003017924A3 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
MXPA03009602A (es) Analogos de nociceptina.
RS20050649A (en) Antibacterial indolone oxazolidinones,intermediates for their preparation and pharmaceutical compositions containing them
ITRM20030363A1 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
AP2004003106A0 (en) Synergistic insecticidal mixtures.
BR0309923B1 (pt) Formulação aquosa de poliuretano, e, uso da mesma
WO2005002592A3 (en) Stable oral compositions of azithromycin monohydrate
BRPI0415285A (pt) derivados de aminoalcanol
AU2003210850A1 (en) N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
TW200509794A (en) Novel anthelmintic and insecticidal compositions
AP9901699A0 (en) Antiparasitic formulations.

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7A E 8A ANUIDADES

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2055 DE 25/05/2010.